Schedule 13G ownership disclosure
Fulcrum Therapeutics Inc
Common Stock · CUSIP: 359616109
Event date: 2025-09-30
- Filing-level shares
- 3,270,322
- Percent of class
- 6.0%
- BlackRock, Inc.
Shares: 3,270,322 · Class: 6.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002012383-25-002864
- Form type
- SCHEDULE 13G/A
- Filer
- BlackRock, Inc.
- CIK
- CIK 2012383
- Filed
- Oct 17, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership